Licensed from Lilly in 2019, Xinermei, also known as mazdutide, is priced at 2,920 yuan ($411) per month for the highest dosage, compared with about $400 for Wegovy and $900 for Mounjaro
GHK-Cu levels decline significantly with age dropping by approximately 60% by age 60 contributing to reduced skin elasticity, fine lines and wrinkles, hair thinning, and slower tissue repair
An oral form and a lower-dose version (Ozempic) approved for type 2 diabetes are also in wide use
The Ozempic effect is finally showing up in obesity data The decline of one of Americas biggest health crises, in two charts
Without it, your nerves might have trouble sending signals to your brain, particularly in your fingers or toes
Supplements showing promise for weight loss Protein Protein is a much-talked-about macronutrient for weight loss today for good reason